NCT00378027View on ClinicalTrials.gov

Arixtra PE Study- Outpatient Management of Stable Acute Pulmonary Embolism: Once Daily Subcutaneous Fondaparinux

WithdrawnOBSERVATIONAL
0
Timeline

Start Date

August 31, 2006

Primary Completion Date

April 30, 2007

Study Completion Date

April 30, 2007

Conditions
Pulmonary Embolism
Interventions
DRUG

Fondaparinux

Administer Fondaparinux Risk Stratify

Trial Locations (1)

44195

Cleveland Clinic 9500 Euclid Ave., Cleveland

Sponsors

Collaborators (1)

GlaxoSmithKline
All Listed Sponsors
collaborator

GlaxoSmithKline

INDUSTRY

lead

The Cleveland Clinic

OTHER

NCT00378027 - Arixtra PE Study- Outpatient Management of Stable Acute Pulmonary Embolism: Once Daily Subcutaneous Fondaparinux | Biotech Hunter | Biotech Hunter